NAVB - Navidea Biopharmaceuticals, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts1111
Avg. Estimate-0.17-0.15-0.74-0.75
Low Estimate-0.17-0.15-0.74-0.75
High Estimate-0.17-0.15-0.74-0.75
Year Ago EPSN/AN/AN/A-0.74
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts1111
Avg. EstimateN/AN/A400kN/A
Low EstimateN/AN/A400kN/A
High EstimateN/AN/A400kN/A
Year Ago SalesN/AN/A847k400k
Sales Growth (year/est)N/AN/A-52.80%N/A
Earnings HistoryInvalid DateInvalid DateInvalid Date6/29/2019
EPS Est.N/AN/AN/A-0.15
EPS ActualN/AN/AN/A-0.24
DifferenceN/AN/AN/A-0.09
Surprise %N/AN/AN/A-60.00%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.17-0.15-0.74-0.75
7 Days Ago-0.17-0.15-0.74-0.75
30 Days Ago-0.17-0.15-0.74-0.75
60 Days Ago-0.17-0.15-0.67-0.74
90 Days Ago-0.17-0.15-0.67-0.74
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNAVBIndustrySectorS&P 500
Current Qtr.N/AN/AN/A-0.02
Next Qtr.N/AN/AN/A0.07
Current YearN/AN/AN/A-0.02
Next Year-1.40%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A